Elevated Down Syndrome Incidence And Maternal Age Is Fueling Growth In Non-Invasive Prenatal Testing Market: A Significant Driver Propelling The Non-invasive Prenatal Testing Market In 2025

The Non-invasive Prenatal Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Non-invasive Prenatal Testing Market Size and Projected Growth Rate?
The non-invasive prenatal testing market has expanded rapidly in recent years. It will increase from $5.48 billion in 2024 to $6.28 billion in 2025 at a compound annual growth rate (CAGR) of 14.7%. This growth can be attributed to improved accuracy in testing, reduced risk for mothers, increased maternal age, growing awareness, and updated clinical guidelines.

The non-invasive prenatal testing market is expected to see rapid expansion, with the market projected to grow to $10.95 billion by 2029 at a CAGR of 14.9%. Growth drivers include broader test availability, maternal age-related concerns, telehealth growth, and better anomaly detection. Trends involve expansion of test panels, increased NIPT adoption, technological progress, and non-invasive fetal diagnosis innovations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

What Are the Major Segments in the Non-invasive Prenatal Testing Market?
The non-invasive prenatal testing market covered in this report is segmented -

1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs

Subsegment:
1) By Consumables: Assay Kits, Reagents, Disposables
2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices, Others (Microarrays And Mass Spectrometers)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

What Are The Driving Non-invasive Prenatal Testing Market Evolution?
The high occurrence of Down syndrome, especially among older mothers, is a major driver of the non-invasive prenatal testing (NIPT) market. Down syndrome, caused by an extra chromosome 21, impacts cognitive and physical development. NIPT offers a safe, non-invasive method to detect the condition with over 99% accuracy and no risk of miscarriage. According to the CDC and National Down Syndrome Society, in the U.S., 1 in 700 babies is born with the condition, with 80% of these births occurring in older women, which supports the increasing demand for NIPT.

Which Firms Dominate The Non-invasive Prenatal Testing Market Segments?
Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

What Trends Are Driving Growth in The Non-invasive Prenatal Testing Market?
The implementation of next-generation sequencing has significantly increased the speed, efficiency, and scalability of DNA sequencing, making it possible to analyze large volumes of genetic material simultaneously. This technology has been adopted by major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad, particularly for non-invasive prenatal testing. Notably, the CFDA approved Annoroad's NextSeq 550AR sequencing system for medical use.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Which Is The Largest Region In The Non-invasive Prenatal Testing Market?
North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Non-invasive Prenatal Testing Market?
2. What is the CAGR expected in the Non-invasive Prenatal Testing Market?
3. What Are the Key Innovations Transforming the Non-invasive Prenatal Testing Industry?
4. Which Region Is Leading the Non-invasive Prenatal Testing Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.